Bio Path | BPTH - Capitale Ordinario





Capitale Ordinario Cambiamento Data
Alterity Therapeutics Limited AUD 213.97M 144.39K 2023-06
Baxter International USD 514.28M 168.72M 2025-12
Bio Path USD 9.24M 934K 2025-09
Cipla INR 807.77M 807.43M 2025-09
Clal Biotechnology ILS 1.61M 0 2022-12
Compugen USD 94.55M 1.02M 2025-12
CSL USD 482.13M 93.87M 2025-12
Grifols EUR 680.58M 846.11K 2025-12
Karyopharm Therapeutics USD 13K 0 2024-09